SG Americas Securities LLC boosted its stake in AvePoint, Inc. (NASDAQ:AVPT – Free Report) by 335.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 2,391,696 shares of the company’s stock after purchasing an additional 1,842,124 shares during the period. SG Americas Securities LLC owned about 1.11% of AvePoint worth $22,745,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AVPT. Morgan Stanley boosted its position in shares of AvePoint by 372.6% during the fourth quarter. Morgan Stanley now owns 7,871,282 shares of the company’s stock worth $109,332,000 after buying an additional 6,205,829 shares during the period. Parsifal Capital Management LP raised its holdings in shares of AvePoint by 61.2% in the 3rd quarter. Parsifal Capital Management LP now owns 8,522,740 shares of the company’s stock valued at $127,926,000 after buying an additional 3,235,384 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of AvePoint by 620.9% in the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,140,572 shares of the company’s stock valued at $29,733,000 after buying an additional 1,843,641 shares during the period. Prudential PLC acquired a new position in AvePoint during the 3rd quarter worth about $26,824,000. Finally, Millennium Management LLC lifted its stake in AvePoint by 583.4% during the 3rd quarter. Millennium Management LLC now owns 1,394,604 shares of the company’s stock worth $20,959,000 after acquiring an additional 1,190,541 shares in the last quarter. Hedge funds and other institutional investors own 44.49% of the company’s stock.
AvePoint Price Performance
AVPT opened at $10.40 on Thursday. The business has a fifty day moving average price of $10.34 and a 200 day moving average price of $11.19. AvePoint, Inc. has a 12 month low of $8.84 and a 12 month high of $19.95. The stock has a market capitalization of $2.21 billion, a price-to-earnings ratio of 49.55 and a beta of 1.18.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on AVPT shares. Scotiabank lowered their target price on AvePoint from $13.00 to $12.00 and set a “sector outperform” rating for the company in a report on Friday, May 8th. William Blair reissued a “market perform” rating on shares of AvePoint in a research note on Monday, March 23rd. Cantor Fitzgerald lowered their price objective on shares of AvePoint from $18.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, February 27th. TD Cowen dropped their price objective on shares of AvePoint from $17.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 27th. Finally, Citigroup cut their target price on shares of AvePoint from $15.00 to $13.00 and set a “neutral” rating on the stock in a research note on Monday, March 2nd. Ten equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $16.44.
Get Our Latest Report on AvePoint
AvePoint Profile
AvePoint, Inc (NASDAQ:AVPT) is a leading software provider specializing in data management, governance, and compliance solutions for Microsoft 365 and related cloud platforms. Founded in 2001 and headquartered in Jersey City, New Jersey, the company offers a comprehensive suite of cloud-based and on-premises tools designed to help organizations migrate, manage, and protect their collaboration data. AvePoint’s flagship Cloud Platform delivers backup, governance, reporting, and migration services for SharePoint, Teams, Exchange, OneDrive, and Salesforce environments.
With a customer base spanning thousands of organizations across more than 100 countries, AvePoint serves enterprises, government agencies, and educational institutions seeking to ensure data security, regulatory compliance, and operational resilience.
Recommended Stories
- Five stocks we like better than AvePoint
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.
